gentuximab
mAbexperimental
Clinical trial activity
4 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Oct 11, 2017 (NCT03313219)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05919381 | Phase 3 | May 30, 2022 | GeneScience Pharmaceuticals Co., Ltd. |
| NCT05223595 | Phase 1 | Apr 2, 2021 | GeneScience Pharmaceuticals Co., Ltd., Jiao Tong University |
| NCT04053205 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2019 | Fujian Medical University, GeneScience Pharmaceuticals Co., Ltd., Harbin Medical University, Huazhong University of Science and Technology, Jiao Tong University, Jilin University, Nanjing Medical University, Sun Yat-Sen University, Zhejiang University, Zhengzhou University |
| NCT03313219 | Phase 1 | Oct 11, 2017 | GeneScience Pharmaceuticals Co., Ltd., Huazhong University of Science and Technology |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GeneScience Pharmaceuticals Co., Ltd. | For profit | 4 | 4 | 3 | 2017 |
| Huazhong University of Science and Technology | Academic/Hospital | 2 | 0 | 2 | 2017 |
| Jiao Tong University | Academic/Hospital | 2 | 0 | 2 | 2019 |
| Fujian Medical University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Harbin Medical University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Jilin University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Nanjing Medical University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Zhengzhou University | Academic/Hospital | 1 | 0 | 1 | 2019 |
10 organizations
Page 1 / 1